Cabaletta Bio, Inc.
CABA
$1.59
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.50% | -43.50% | -56.02% | -86.22% | -90.53% |
| Total Depreciation and Amortization | 9.86% | 23.41% | 39.29% | 19.44% | 15.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.44% | 60.61% | 77.55% | 137.47% | 101.38% |
| Change in Net Operating Assets | 13,212.90% | 26.22% | 339.45% | 428.83% | 96.77% |
| Cash from Operations | -46.36% | -28.41% | -40.58% | -61.24% | -74.86% |
| Capital Expenditure | 79.09% | 3.33% | -103.24% | -289.23% | -1,250.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.14% | -- | 846.25% | -- | 150.95% |
| Cash from Investing | -307.32% | 3.33% | 967.25% | 18,941.54% | 149.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25,328.76% | -- | -94.34% | -27.55% | -99.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24,536.68% | -108.05% | -95.30% | -27.55% | -99.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 315.12% | -79.06% | -108.55% | 36.32% | -90.30% |